BIBW-2992

5 mg

Cat. No.: 72-C33

$89.00

BIBW-2992 is a irreversible and dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) kinases.  The potency of BIBW-2992 on the EGFR and HER2 kinases revealed IC₅₀ values of 0.5 nM and 14 nM, respectively. BIBW-2992 is highly selective for these kinases and no additional inhibition of other kinases has been observed. BIBW-2992 has also been shown to suppress EGF-induced EGFR phosphorylation and cellular proliferation in various cell lines.

Categories: ,

Details

TECHNICAL INFORMATION

Other Names: Afatinib

Chemical Formula:  C24H25ClFN5O3

CAS Number: 850140-72-6

Molecular Weight: 485.94

Purity:  >98%

Appearance:  a crystalline solid 

Solubility: DMSO

 

STORAGE AND HANDLING

Storage: Store at 4°C and protected from light. Following reconstitution, store aliquots at -20°C. 

Stability: Stock solutions stable at -20°C for up to 2 years.

Shipping Conditions: Shipped at room temperature.

 

PRODUCT USE

Soluble in DMSO at 200 mg/ml. Soluble in ethanol at 25mg/ml. If precipitate is observed,  vortex for 5 minutes. For most cells, the maximum tolerance to DMSO is less than 0.5%.  

References

Li et al. (2008) BIBW2992 | an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene. 27(34):4702-11.

Takezawa et al. (2010) Enhanced anticancer effect of the combination of BIBW2992 and thymidylate synthase-targeted agents in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor. Mol Cancer Ther. 9(6):1647-56.

Minkovsky et al. (2008) BIBW-2992 | a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors. Curr Opin Investig Drugs. 9(12): 1336-46.

Tech Docs

Product Specifications

MSDS